http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101021402-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
filingDate | 2008-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101021402-B1 |
titleOfInvention | NMD regulation method using gene PNCR2 |
abstract | The present invention provides a gene PNRC2 that can control nonsense-mediated mRNA disruption (hereinafter referred to as 'NMD') and an artificially controlled NMD using the same. Provide a method. Through the molecular biological understanding of NMD and artificial NMD efficiency control technology according to the present invention, it is possible to develop therapeutic agents or inhibitors of NMD-related genetic diseases and cancers.n n n n NMD, PNRC2, Upf1, Dcp1a |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022177269-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022177267-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102378381-B1 |
priorityDate | 2008-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 170.